Similarly, effects on children and adolescents are unknown, and use in these populations cannot be recommended
Growth hormone therapy can induce insulin resistance, elevate fasting glucose, worsen glycemic control in diabetics or pre-diabetics, increase risk of developing type 2 diabetes with long-term use, and require medication adjustments for individuals with existing diabetes
The frequency and severity of gastrointestinal symptoms can vary depending on the formulation (tablets, sublingual preparations, or liquid forms), the dose administered, and individual patient factors such as existing digestive conditions or sensitivities to inactive ingredients in the supplement
These factors may seem unrelated to peptide dosing, but they substantially impact outcomes
Homocysteine and dementia: an international Consensus Statement
Our personalized plans ensure that clients receive only what is necessary for their bodies